|Bid||0.00 x N/A|
|Ask||0.00 x N/A|
|Day's Range||136.00 - 138.00|
|52 Week Range||91.46 - 138.00|
|Beta (3Y Monthly)||0.41|
|PE Ratio (TTM)||47.59|
|Forward Dividend & Yield||1.41 (1.04%)|
|1y Target Est||N/A|
Stocks traded near session highs as the S&P; 500 today climbed close to a record peak and Alphabet neared a buy point.
After several tireless days we have finished crunching the numbers from nearly 750 13F filings issued by the elite hedge funds and other investment firms that we track at Insider Monkey, which disclosed those firms' equity portfolios as of June 28. The results of that effort will be put on display in this article, as […]
With more than 10 million cloud-connected CPAP and other breathing devices on the market, CEO Mick Farrell completely understands why patients are wary about letting those devices send data to the cloud.
President and COO ResMed Inc. of Resmed Inc (30-Year Financial, Insider Trades) Robert Andrew Douglas (insider trades) sold 4,111 shares of RMD on 07/15/2019 at an average price of $124.5 a share. Continue reading...
CEO of Resmed Inc (NYSE:RMD) Michael J. Farrell sold 6,651 shares of RMD on 07/08/2019 at an average price of $123.76 a share.
During Friday night's Lightning Round of Mad Money, Jim Cramer said this about ResMed Inc. In the daily bar chart of RMD, below, we can see a wide-swinging sideways market for this stock. The daily On-Balance-Volume (OBV) line has been steady from March, and is close to making a new high for the move up.
The San Diego-based company said it had net income of 73 cents per share. Earnings, adjusted for amortization costs and pretax expenses, came to 89 cents per share. The results exceeded Wall Street expectations. ...
It’s time for the one-year update on a set of stocks that David Gardner picked to commemorate April the giraffe giving birth live on YouTube.
ResMed gapped up out of a downward-sloping flat base, surging on earnings. The maker of sleep apnea products reported better-than-expected earnings growth and the third straight quarter of slowly accelerating revenue growth.
Mick Farrell, ResMed CEO, joined Yahoo Finance from the New York Stock Exchange as the company celebrates its 20th year as a publicly traded company.